Abstract:Aim To prepare a solid dispersion of cisapride with hydroxypropylmethyl cellulose (HPMC E5 LV) as carrier for the purpose of accelerating the in vitro drug release by means of improving the solubility of the model drug. Methods Alcohol and simulated gastric fluid (SGF) were used to dissolve cisapride and HPMC in order to make the model drug dispersed homogeneously in the carrier. The HPMC-cisapride solid dispersion was then obtained by conventional solvent evaporation method. Powder X-ray diffraction (XRD) was used to measure the diffraction peaks of pure carrier, pure cisapride, physical mixture of HPMC with cisapride (4∶1), and HPMC-cisapride solid dispersion (4∶1) to confirm the crystal existence. The solubility of pure drug and HPMC-cisapride solid dispersion was measured with water, SGF and simulated intestinal fluid (SIF). The in vitro drug releases of the sustained release tablet prepared with pure cisapride or HPMC-cisapride solid dispersion were investigated with water and SGF as media, respectively. Results No diffraction peaks were found by X-ray diffraction in the HPMC-cisapride solid dispersion (4∶1), indicating that the drug existed in an amorphous form at that drug-carrier ratio. Compared with the pure drug, the solubilities of HPMC-cisapride solid dispersion are increased by 239.4% in SGF, 132.6% in water, and 117.9% in SIF. According to the in vitro drug release, the sustained release tablet prepared with HPMC-cisapride solid dispersion had a faster drug release than did that prepared with pure drug. The in vitro drug release profiles were found to comply with Higuchi's rule. Conclusion The in vitro drug release of the sustained release tablet made by HPMC-cisapride solid dispersion is improved owing to the increased drug solubility.

Stabilization of Solid Dispersions of 10-Hydroxycampothecin in Polyethylene Glycol

Monolithic Osmotic Tablet Containing Solid Dispersion of 10-Hydroxycamptothecin

Enhanced Stability of the Pharmacologically Active Lactone Form of 10-Hydroxycamptothecin by Self-Microemulsifying Drug Delivery Systems

Preparation, Characterization and in Vitro Evaluation of Solid Dispersions Containing Docetaxel

Development of a chemically stable 10-hydroxycamptothecin nanosuspensions

Solidification Studies of Polyethylene Glycols, Gelucire 44/14 or their Dispersions with Triamterene or Temazepam

[Comparison of bioavailability of two kinds of solid dispersion from 10-hydroxycamptothecin in SD rats in vivo].

Encapsulation of 10-Hydroxy Camptothecin in Supramolecular Hydrogel As an Injectable Drug Delivery System

Dissolution improvement of high drug-loaded solid dispersion

Preparation and In Vitro Evaluation of Solid Dispersions of Total Flavones of Hippophae rhamnoides L.

Impact of HPMCAS on the Dissolution Performance of Polyvinyl Alcohol Celecoxib Amorphous Solid Dispersions

Application of HPMC HME polymer as hot melt extrusion carrier in carbamazepine solid dispersion

Polymers Enhance Chlortetracycline Hydrochloride Solubility

Preparation, Characterization and Pharmacokinetics of 10-Hydroxy-camptothecin Nanosuspension

Improving the Dissolution Rate of Poorly Water Soluble Drug by Solid Dispersion and Solid Solution—Pros and Cons

Dissolution Improvement of Cisapride by Solid Dispersion with HPMC

Studies on Preparation and in vitro Evaluation of Tacrolimus Solid Dispersions

FTIR spectroscopic study of poly(ethylene glycol)-nifedipine dispersion stability in different relative humidities

Preparation, physicochemical and pharmacological study of 10-hydroxycamptothecin solid dispersion with complexation agent – xylan-nonanoic acid amphiphilic conjugates

Preparation and Physicochemical Characterization of Solid Dispersion of Quercetin and Polyvinylpyrrolidone

The Effect of Cooling on the Degree of Crystallinity, Solid-State Properties, and Dissolution Rate of Multi-Component Hot-Melt Extruded Solid Dispersions